/R E P E A T -- Media Advisory - Minister Mendicino to make a funding announcement/
MONTRÉAL, March 31, 2022 /CNW/ - Members of the media are invited to join the Honourable Marco Mendicino, Minister of Public Safety, for a funding announcement to prevent gun violence and to strengthen local efforts to counter criminal behaviour.
Following the announcement, Minister Mendicino will take questions from the media.
Media representatives who wish to attend the event must arrive at least 15 minutes in advance to sign in and present photo ID and credentials.
Media who wish to participate by phone can dial-in by using the numbers below. Media are encouraged to dial-in 15 minutes before the start of the news conference. Teleconference participants will be able to ask questions.
Media and guests are asked to respect local physical distancing guidelines. Participants will be required to share their name and phone number for possible contact tracing. Wearing masks is required, especially when not able to maintain physical distance.
Savara Inc. , a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will participate in a fireside chat at the Citizens JMP Life Science Conference on May 14, 2024 at 6:00am...
Janux Therapeutics, Inc. (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technology to its Tumor Activated T Cell Engager (TRACTr) and Tumor Activated...
AbCellera today announced financial results for the first quarter of 2024. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated.
"We continue to execute on advancing our internal pipeline,...
Veracyte, Inc. today announced financial results for the first quarter ended March 31, 2024.
"We had a strong start to 2024, driven by robust growth from our market-leading Decipher Prostate and Afirma tests. We executed upon our strategies to...
Pulse Biosciences, Inc. , a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablationtm (nsPFAtm) technology, today announced business updates and financial results for the first quarter ended March 31, 2024.
Recent...